Candida auris: what have we learned so far?
Authors:
- 1 December 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 32 (6) , 559-564
Abstract
The increasing prevalence of fungal infections due to Candida species has been well described in critically ill patient populations, but in recent years a new species, Candida auris has received attention from the medical community worldwide. We aim to summarize the current knowledge related to C. auris, as new identification techniques, novel antifungal agents and more experience with outbreak management have been published in the past few years. C. auris has been described in several countries, arising independently in separate clades. Its resistance to multiple antifungals and persistent colonization of patients and medical surfaces have become a therapeutic and infection control challenge. Recent elucidation of some of the molecular mechanisms related to pathogenicity and studies of in-vitro efficacy of novel antifungal agents can better guide therapy. As C. auris continues to cause outbreaks worldwide, newer, and more efficient identification techniques, novel antifungals, and more knowledge in effective infection control techniques will allow better clinical outcomes in the management and control of invasive fungal disease.Keywords
This publication has 16 references indexed in Scilit:
- Candida auris: What Have We Learned About Its Mechanisms of Pathogenicity?Frontiers in Microbiology, 2018
- Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic optionsMicrobial Pathogenesis, 2018
- Filamentation in Candida auris , an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switchEmerging Microbes & Infections, 2018
- A Candida auris Outbreak and Its Control in an Intensive Care SettingNew England Journal of Medicine, 2018
- Emerging Fungal Pathogen Candida auris Evades Neutrophil AttackmBio, 2018
- Candida auris: An emerging drug resistant yeast – A mini-reviewJournal of Medical Mycology, 2018
- In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida aurisAntimicrobial Agents and Chemotherapy, 2018
- Candida auris: an Emerging Fungal PathogenJournal of Clinical Microbiology, 2018
- Candida auris: a Review of the LiteratureClinical Microbiology Reviews, 2018
- Candida auris candidaemia in Indian ICUs: analysis of risk factorsJournal of Antimicrobial Chemotherapy, 2017